Inceptionr LLC purchased a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 2,028 shares of the semiconductor company’s stock, valued at approximately $804,000.
Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. lifted its holdings in shares of Synopsys by 1.6% during the fourth quarter. Vanguard Group Inc. now owns 18,464,862 shares of the semiconductor company’s stock valued at $8,673,315,000 after purchasing an additional 283,677 shares during the last quarter. State Street Corp lifted its stake in Synopsys by 0.3% during the 4th quarter. State Street Corp now owns 8,788,890 shares of the semiconductor company’s stock valued at $4,128,317,000 after acquiring an additional 28,532 shares during the period. Morgan Stanley boosted its holdings in Synopsys by 2.5% in the fourth quarter. Morgan Stanley now owns 4,573,980 shares of the semiconductor company’s stock worth $2,148,491,000 after purchasing an additional 109,917 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Synopsys by 1.3% in the 4th quarter. Geode Capital Management LLC now owns 4,310,846 shares of the semiconductor company’s stock worth $2,017,256,000 after buying an additional 54,329 shares during the last quarter. Finally, Van ECK Associates Corp boosted its position in Synopsys by 17.0% in the fourth quarter. Van ECK Associates Corp now owns 2,593,619 shares of the semiconductor company’s stock worth $1,218,275,000 after purchasing an additional 376,711 shares during the last quarter. 85.47% of the stock is owned by institutional investors.
Insider Buying and Selling
In related news, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the transaction, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the sale, the chief executive officer owned 75,020 shares in the company, valued at $34,431,179.20. This represents a 16.29% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by corporate insiders.
Synopsys Price Performance
Synopsys (NASDAQ:SNPS – Get Free Report) last released its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, beating the consensus estimate of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The business had revenue of $2.28 billion during the quarter, compared to analysts’ expectations of $2.25 billion. During the same quarter last year, the business posted $3.67 EPS. The firm’s revenue for the quarter was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, equities research analysts forecast that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.
Analysts Set New Price Targets
A number of equities analysts recently issued reports on SNPS shares. Piper Sandler raised shares of Synopsys from a “neutral” rating to an “overweight” rating and raised their price objective for the stock from $450.00 to $550.00 in a report on Tuesday, June 23rd. Needham & Company LLC reiterated a “buy” rating and issued a $580.00 price target on shares of Synopsys in a research report on Thursday, May 28th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Synopsys in a research note on Monday, June 8th. Zacks Research raised shares of Synopsys from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, June 30th. Finally, KeyCorp restated an “overweight” rating on shares of Synopsys in a research note on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $570.06.
View Our Latest Stock Analysis on SNPS
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
- Five stocks we like better than Synopsys
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
